SeaStar Medical Holding Corporation (ICU)

R&D to Revenue

609.24%

Fiscal year · Period ending:

ICU logo

ICU R&D to Revenue

Latest reported609.24%
ICU FY R&D/Revenue (0.00% → 609.24%)
High-resolution chart · PNG

ICU r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

SeaStar Medical Holding Corporation R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
609.2382%
6,744.4444%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.